← Back to Search

Diagnostic Test

Standard of Care: Angiography, OCT, FFR, and VFR for Coronary Artery Disease (FUSION Trial)

N/A
Waitlist Available
Led By Allen Jeremias, MD
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour
Awards & highlights

Summary

This trial is comparing two ways of measuring how well blood flows through the heart.

Eligible Conditions
  • Coronary Artery Disease
  • Coronary Artery Stenosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sensitivity and specificity of Virtual Flow Reserve (VFR) against Fractional Flow Reserve (FFR)
Secondary study objectives
Area under curve (AUC) against FFR
Correlation between VFR and FFR
Negative predictive value (NPV)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Standard of Care: Angiography, OCT, FFR, and VFRExperimental Treatment4 Interventions
Patients will have Pre-OCT Angiography, OCT pullbacks, a FFR measurement and a VFR analysis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ICA (Invasive Coronary Angiography)
2020
N/A
~1040
OCT
2016
N/A
~1270
FFR
2020
N/A
~3180

Find a Location

Who is running the clinical trial?

Abbott Medical DevicesLead Sponsor
647 Previous Clinical Trials
408,222 Total Patients Enrolled
103 Trials studying Coronary Artery Disease
126,690 Patients Enrolled for Coronary Artery Disease
Allen Jeremias, MDPrincipal InvestigatorSt. Francis Hospital,Roslyn,NY, United States
1 Previous Clinical Trials
260 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
260 Patients Enrolled for Coronary Artery Disease
~60 spots leftby Sep 2025